Time-shifting effects of methylphenidate on daily rhythms in the diurnal rodent Arvicanthis ansorgei

Psychopharmacology
Jorge MendozaJohanna H Meijer

Abstract

People suffering of attention-deficit/hyperactivity disorder (ADHD) and treated with the psychostimulant methylphenidate (MPH) show sleep-wake cycle and daily rhythm alterations despite the beneficial effects of MPH on behavioral symptoms (i.e., hyperactivity, attention). In nocturnal rodents (i.e., mice), chronic exposure to MPH alters the neural activity of the circadian clock in the suprachiasmatic nucleus (SCN), behavioral rhythms, and the sleep-wake cycle. Here, we studied the effects of MPH on daily rhythms of behavior and body temperature of the diurnal rodent Arvicanthis ansorgei. Under a light-dark cycle, chronic exposure to MPH in drinking water delayed the onset of both activity and body temperature rhythms. Interestingly, delays were larger when MPH access was restricted to the first 6 h of the light phase (i.e., activity phase) of the 24-h cycle. Since MPH effects are dependent on animal's fluid intake, in a last experiment, we controlled the time and dose of MPH delivery in Arvicanthis using an intraperitoneal perfusion method. Similarly to the experiment with MPH in drinking water, Arvicanthis showed a delay in the onset of general activity and body temperature when MPH infusions, but not vehicle, were during the...Continue Reading

References

Aug 1, 1996·Biological Reviews of the Cambridge Philosophical Society·N Mrosovsky
Jan 1, 1997·Life Sciences·O GaytanN Dafny
Feb 17, 1998·Journal of Comparative Physiology. A, Sensory, Neural, and Behavioral Physiology·K J Bobrzynska, N Mrosovsky
May 4, 2000·Brain Research·O GaytanN Dafny
Jun 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·Carolina AbarcaRainer Spanagel
Jun 28, 2003·Journal of Biological Rhythms·Johanna H Meijer, William J Schwartz
Sep 24, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·George SchwartzRidha Joober
Jun 14, 2005·Biological Psychiatry·Steven R Pliszka
Aug 4, 2005·Chronobiology International·Kristiaan B Van der HeijdenW Boudewijn Gunning
Jul 21, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amy F T Arnsten
Jul 19, 2008·Trends in Molecular Medicine·William Renthal, Eric J Nestler
Nov 26, 2008·Pharmacology, Biochemistry, and Behavior·Mohamed F AlgahimNachum Dafny
Sep 18, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George Bush
Feb 13, 2010·Annual Review of Physiology·David K WelshSteve A Kay
Jun 20, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Verônica ContiniClaiton H D Bau
Jul 5, 2012·PloS One·Floor van OosterhoutJohanna H Meijer
Jul 6, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael C AntleJohanna H Meijer
Jul 19, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paul L SotoMichael R Weed
Oct 24, 2012·Journal of Psychiatric Research·Antonio Molina-CarballoAntonio Muñoz-Hoyos
Aug 13, 2013·Psychopharmacology·Anthony J HutchinsonMargarita L Dubocovich

❮ Previous
Next ❯

Citations

Feb 14, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A N CooganF Faltraco

❮ Previous
Next ❯

Software Mentioned

ClockLab
STATISTICA

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

© 2022 Meta ULC. All rights reserved